an animal model system for aspergillosis in balb/c mice has been developed to evaluate the therapeutic efficacy of liposomal amphotericin-b ( amp-b ) and commercial amp-b ( fungizone ) .
C1145701
liposomal amphotericin-b
C0002679
amp-b